Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
The Phase 2 trial duration of 48 weeks provides good medium-term data, but multi-year outcomes will emerge only as Phase 3 trials complete and post-marketing surveillance accumulates
In many treatment plans, it may also help with weight reduction, because it can reduce appetite, slow stomach emptying, and help people feel full sooner
In modern medicine, many individuals are prescribed spironolactone for its anti-androgen properties
This formula has been widely used for alcohol administration studies, the formula accounts for (1) time spent drinking, (2) time post-consumption, (3) total body water, (4) sex, (5) age, (6) weight, (7) height, and (8) estimated alcohol elimination rate